BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18042721)

  • 1. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
    Feigin A; Kaplitt MG; Tang C; Lin T; Mattis P; Dhawan V; During MJ; Eidelberg D
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19559-64. PubMed ID: 18042721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.
    Emborg ME; Carbon M; Holden JE; During MJ; Ma Y; Tang C; Moirano J; Fitzsimons H; Roitberg BZ; Tuccar E; Roberts A; Kaplitt MG; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):501-9. PubMed ID: 16835631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
    Kaplitt MG; Feigin A; Tang C; Fitzsimons HL; Mattis P; Lawlor PA; Bland RJ; Young D; Strybing K; Eidelberg D; During MJ
    Lancet; 2007 Jun; 369(9579):2097-105. PubMed ID: 17586305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
    Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
    Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of a randomized AAV2-
    Niethammer M; Tang CC; LeWitt PA; Rezai AR; Leehey MA; Ojemann SG; Flaherty AW; Eskandar EN; Kostyk SK; Sarkar A; Siddiqui MS; Tatter SB; Schwalb JM; Poston KL; Henderson JM; Kurlan RM; Richard IH; Sapan CV; Eidelberg D; During MJ; Kaplitt MG; Feigin A
    JCI Insight; 2017 Apr; 2(7):e90133. PubMed ID: 28405611
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.
    Niethammer M; Tang CC; Vo A; Nguyen N; Spetsieris P; Dhawan V; Ma Y; Small M; Feigin A; During MJ; Kaplitt MG; Eidelberg D
    Sci Transl Med; 2018 Nov; 10(469):. PubMed ID: 30487248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network modulation in the treatment of Parkinson's disease.
    Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
    Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson's disease.
    Diaz-Nido J
    Curr Opin Investig Drugs; 2010 Jul; 11(7):813-22. PubMed ID: 20571977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease.
    Barbero JA; Unadkat P; Choi YY; Eidelberg D
    Neurotherapeutics; 2023 Oct; 20(6):1653-1668. PubMed ID: 37684533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.
    Hirano S; Eckert T; Flanagan T; Eidelberg D
    Mov Disord; 2009; 24 Suppl 2(0 2):S725-31. PubMed ID: 19877247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic changes following subthalamotomy for advanced Parkinson's disease.
    Su PC; Ma Y; Fukuda M; Mentis MJ; Tseng HM; Yen RF; Liu HM; Moeller JR; Eidelberg D
    Ann Neurol; 2001 Oct; 50(4):514-20. PubMed ID: 11601502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Langner-Lemercier S; Drapier S; Naudet F; Le Clanche N; Houvenaghel JF; Sauleau P; Jannin P; Haegelen C; Le Jeune F; Vérin M
    J Neurol; 2015; 262(4):881-9. PubMed ID: 25634679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network modulation following sham surgery in Parkinson's disease.
    Ko JH; Feigin A; Mattis PJ; Tang CC; Ma Y; Dhawan V; During MJ; Kaplitt MG; Eidelberg D
    J Clin Invest; 2014 Aug; 124(8):3656-66. PubMed ID: 25036712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.
    LeWitt PA; Rezai AR; Leehey MA; Ojemann SG; Flaherty AW; Eskandar EN; Kostyk SK; Thomas K; Sarkar A; Siddiqui MS; Tatter SB; Schwalb JM; Poston KL; Henderson JM; Kurlan RM; Richard IH; Van Meter L; Sapan CV; During MJ; Kaplitt MG; Feigin A
    Lancet Neurol; 2011 Apr; 10(4):309-19. PubMed ID: 21419704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study.
    Arai N; Yokochi F; Ohnishi T; Momose T; Okiyama R; Taniguchi M; Takahashi H; Matsuda H; Ugawa Y
    J Neurol; 2008 Aug; 255(8):1236-43. PubMed ID: 18563467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
    Zhao YB; Sun BM; Li DY; Wang QS
    Chin Med J (Engl); 2004 Sep; 117(9):1304-8. PubMed ID: 15377418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.